MY101916A - Etoposide oral dosage form. - Google Patents
Etoposide oral dosage form.Info
- Publication number
- MY101916A MY101916A MYPI87002211A MYPI19872211A MY101916A MY 101916 A MY101916 A MY 101916A MY PI87002211 A MYPI87002211 A MY PI87002211A MY PI19872211 A MYPI19872211 A MY PI19872211A MY 101916 A MY101916 A MY 101916A
- Authority
- MY
- Malaysia
- Prior art keywords
- dosage form
- oral dosage
- etoposide
- etoposide oral
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59114484A | 1984-03-19 | 1984-03-19 | |
GB08506943A GB2155789B (en) | 1984-03-19 | 1985-03-18 | Etoposide capsules |
Publications (1)
Publication Number | Publication Date |
---|---|
MY101916A true MY101916A (en) | 1992-02-15 |
Family
ID=24365235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI87002211A MY101916A (en) | 1984-03-19 | 1987-09-29 | Etoposide oral dosage form. |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS60209516A (el) |
KR (1) | KR850006136A (el) |
AT (1) | AT392904B (el) |
AU (1) | AU571308B2 (el) |
BE (1) | BE901963A (el) |
CA (1) | CA1238578A (el) |
CH (1) | CH662731A5 (el) |
DE (1) | DE3509741A1 (el) |
DK (1) | DK164535C (el) |
EG (1) | EG17521A (el) |
ES (1) | ES8702140A1 (el) |
FI (1) | FI84023C (el) |
FR (1) | FR2561104B1 (el) |
GB (1) | GB2155789B (el) |
GR (1) | GR850688B (el) |
IE (1) | IE58340B1 (el) |
IL (1) | IL74615A (el) |
IT (1) | IT1187640B (el) |
LU (1) | LU85812A1 (el) |
MY (1) | MY101916A (el) |
NL (1) | NL8500739A (el) |
NO (1) | NO170569C (el) |
NZ (1) | NZ211078A (el) |
OA (1) | OA07968A (el) |
PT (1) | PT80131B (el) |
SE (1) | SE8501312L (el) |
YU (1) | YU45243B (el) |
ZA (1) | ZA851935B (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60239418A (ja) * | 1984-05-15 | 1985-11-28 | Nippon Kayaku Co Ltd | エトポシド軟カプセル製剤 |
JPS61189230A (ja) * | 1985-02-19 | 1986-08-22 | Nippon Kayaku Co Ltd | エトポシド製剤 |
DE3629386A1 (de) * | 1986-08-29 | 1988-03-03 | Scherer Gmbh R P | Gelatinekapseln und verfahren zu ihrer herstellung |
US4927638A (en) * | 1986-10-08 | 1990-05-22 | Bristol-Myers Company | Etoposide solutions |
US5154930A (en) * | 1987-03-05 | 1992-10-13 | The Liposome Company, Inc. | Pharmacological agent-lipid solution preparation |
US5376381A (en) * | 1988-02-25 | 1994-12-27 | The Liposome Company, Inc. | Integrity protected gelatin |
JP2000247911A (ja) * | 1999-02-26 | 2000-09-12 | Hisamitsu Pharmaceut Co Inc | 大腸用吸収促進剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH580255A5 (el) * | 1974-06-04 | 1976-09-30 | Calinter Sa | |
DE2452785A1 (de) * | 1974-11-07 | 1976-05-13 | Universal Oil Prod Co | Verfahren zum betrieb einer verbrennungsmaschine |
FR2358144A1 (fr) * | 1976-07-13 | 1978-02-10 | Lipha | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
JPS5940137B2 (ja) * | 1976-10-14 | 1984-09-28 | 武田薬品工業株式会社 | 経口投与用医薬組成物 |
FR2410504A1 (fr) * | 1977-12-05 | 1979-06-29 | Air Liquide | Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede |
DE2809543A1 (de) * | 1978-03-06 | 1979-09-13 | Werner Henke | Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen |
JPS60239418A (ja) * | 1984-05-15 | 1985-11-28 | Nippon Kayaku Co Ltd | エトポシド軟カプセル製剤 |
-
1985
- 1985-02-08 NZ NZ211078A patent/NZ211078A/en unknown
- 1985-02-20 AU AU38975/85A patent/AU571308B2/en not_active Ceased
- 1985-03-05 FR FR8503221A patent/FR2561104B1/fr not_active Expired
- 1985-03-14 IT IT19897/85A patent/IT1187640B/it active
- 1985-03-14 NL NL8500739A patent/NL8500739A/nl not_active Application Discontinuation
- 1985-03-14 ZA ZA851935A patent/ZA851935B/xx unknown
- 1985-03-15 NO NO851022A patent/NO170569C/no unknown
- 1985-03-15 IL IL74615A patent/IL74615A/xx unknown
- 1985-03-15 YU YU420/85A patent/YU45243B/xx unknown
- 1985-03-15 IE IE68685A patent/IE58340B1/en not_active IP Right Cessation
- 1985-03-15 FI FI851040A patent/FI84023C/fi not_active IP Right Cessation
- 1985-03-16 EG EG164/85A patent/EG17521A/xx active
- 1985-03-18 LU LU85812A patent/LU85812A1/fr unknown
- 1985-03-18 SE SE8501312A patent/SE8501312L/ not_active Application Discontinuation
- 1985-03-18 BE BE0/214666A patent/BE901963A/fr not_active IP Right Cessation
- 1985-03-18 JP JP60054088A patent/JPS60209516A/ja active Pending
- 1985-03-18 DE DE19853509741 patent/DE3509741A1/de not_active Withdrawn
- 1985-03-18 PT PT80131A patent/PT80131B/pt not_active IP Right Cessation
- 1985-03-18 KR KR1019850001736A patent/KR850006136A/ko not_active Application Discontinuation
- 1985-03-18 CA CA000476750A patent/CA1238578A/en not_active Expired
- 1985-03-18 GB GB08506943A patent/GB2155789B/en not_active Expired
- 1985-03-18 ES ES541370A patent/ES8702140A1/es not_active Expired
- 1985-03-18 DK DK122285A patent/DK164535C/da not_active IP Right Cessation
- 1985-03-19 OA OA58543A patent/OA07968A/xx unknown
- 1985-03-19 CH CH1223/85A patent/CH662731A5/de not_active IP Right Cessation
- 1985-03-19 GR GR850688A patent/GR850688B/el unknown
- 1985-03-19 AT AT819/85A patent/AT392904B/de not_active IP Right Cessation
-
1987
- 1987-09-29 MY MYPI87002211A patent/MY101916A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR900100659A (en) | Dosage form for administering oral hupoglycemic glipizide | |
IT7849462A0 (it) | Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione | |
MY8600471A (en) | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof | |
GB2178965B (en) | Devices for administering medicaments to patients | |
ES2040232T3 (es) | Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina. | |
GB2042888B (en) | Preparation for administration to the mucosa of the oral or nasal cavity | |
NO177177C (no) | Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans | |
GB2199031B (en) | Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs | |
AU1578688A (en) | Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines | |
JPS5555113A (en) | Oral administration medical tablet and its manufacture | |
MY103741A (en) | Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process | |
EP0137543A3 (en) | Pharmaceutical composition for the therapy of peripheral arteriopathies | |
MY101916A (en) | Etoposide oral dosage form. | |
DE3568944D1 (en) | Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition | |
KR870005642A (ko) | 디플루니살과 트로메타민의 혼합물 | |
MY8500525A (en) | Pharmaceutical preparation for administration to the mucosa of the oral or nasal cavity | |
GB8525067D0 (en) | Administering medicaments to patients | |
ZA865655B (en) | Devices for administering medicaments to patients |